WellTheory, a digital well being firm for autoimmune illness, introduced on Tuesday that it has raised $14 million in Collection A funding, which is able to assist the corporate scale and advance its AI.
Atherton, California-based WellTheory treats autoimmune situations equivalent to Addison’s illness, celiac illness, a number of sclerosis and lupus. Utilizing a collaborative care mannequin, it companions with sufferers’ physicians to ship personalised plans targeted on diet, stress, sleep and motion. The corporate presents video periods, limitless skilled messaging and diagnostics. It serves each employers and well being plans.
The Collection A spherical was led by Common Catalyst and included participation from 7wireVentures, Ingeborg Investments, Accel, Field Group, Leaps by Bayer and Up2 Alternative Fund. In whole, WellTheory has raised $26.2 million.
“WellTheory is addressing the affect of autoimmune illness by recognizing the vital position that weight loss program and way of life can play in supporting sufferers. The platform is demonstrating how this sort of assist will be delivered at scale, and that is only the start. It’s increasing to combine medical therapy and drugs administration, making a extra complete mannequin designed to enhance affected person experiences and strengthen system sustainability,” mentioned Candace Richardson, companion at Common Catalyst, in an announcement. Richardson is becoming a member of WellTheory’s board.
The financing will assist broaden Welltheory’s partnerships with new and present clients, in keeping with Ellen Rudolph, CEO and co-founder of WellTheory.
“We’ll be increasing our applications for a number of the costliest autoimmune situations and accelerating the event of our AI capabilities,” she added in an e-mail. “These efforts will assist us ship whole-person autoimmune care at scale — enhancing high quality of life for our members whereas driving vital value financial savings for our companions.”
Since launching within the industrial market about 18 months in the past, WellTheory has secured a number of main employer shoppers, together with Dayforce, Fortune Manufacturers Improvements and Maven Clinic. It additionally introduced in June that it’s working with Sentara Well being Plans.
The funding announcement comes at a time when greater than 50 million Individuals battle autoimmune situations, together with rheumatoid arthritis, lupus and a number of sclerosis. The autoimmune therapy market is increasing quickly, valued at greater than $166 billion in 2024.
WellTheory finally goals to scale to fulfill this demand, in keeping with Rudolph.
“We’re getting into our subsequent part of progress, targeted on increasing entry to our mannequin by means of new employer and payor partnerships, investing in AI that permits extra exact and compassionate care, and persevering with to construct proof for our outcomes. … Our north star stays the identical: making high-quality, whole-person take care of autoimmune illness accessible, reasonably priced, and sustainable for sufferers and the healthcare system alike,” she mentioned.
Image: Feodora Chiosea, Getty Photographs
